Form 4: IGM Biosciences Director Michael Lee Receives Stock as Quarterly Retainer

Director Michael Lee of IGM Biosciences reports acquisition of 1,734 shares of common stock as a quarterly retainer, with beneficial ownership disclaimed as he holds the securities on behalf of Redmile Group, LLC.

Summary

• Michael Lee, a director of IGM Biosciences, reported acquiring 1,734 shares of common stock on September 30, 2024.
• The acquisition was a result of a quarterly retainer paid in common stock, according to the Issuer's Outside Director Compensation Policy.
• Lee disclaims beneficial ownership of these securities, as he holds them as a nominee for Redmile Group, LLC, and has assigned all economic, pecuniary, and voting rights to Redmile.
• Following the transaction, Lee directly owns 9,322 shares.
• Jeremy Green, as the principal of Redmile, may also be deemed a beneficial owner, but both Redmile and Green disclaim beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing related to director compensation. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Management Comments

• Mr. Lee was elected to the board of directors of the Issuer as a representative of Redmile and its affiliates.
• Mr. Lee disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, providing transparency to the market regarding the holdings and transactions of company insiders. It is common for directors to receive stock as part of their compensation.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is part of the standard director compensation.

Key Dates